ARID1A
CTNNB1/β-catenin
endometrial cancer
high-risk endometrial cancer
molecular classification
prognosis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Feb 2021
25 Feb 2021
Historique:
received:
17
01
2021
revised:
11
02
2021
accepted:
17
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
7
3
2021
Statut:
epublish
Résumé
The collaborative Cancer Genome Atlas (TCGA) project identified four distinct prognostic groups of endometrial carcinoma (EC) based on molecular alterations: (i) the ultramutated subtype that encompasses
Identifiants
pubmed: 33668727
pii: cancers13050950
doi: 10.3390/cancers13050950
pmc: PMC7956405
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Nat Commun. 2019 Aug 7;10(1):3554
pubmed: 31391455
Cancer. 2017 Mar 1;123(5):802-813
pubmed: 28061006
Eur J Cancer. 2015 Sep;51(13):1742-50
pubmed: 26049688
Mod Pathol. 2018 Oct;31(10):1553-1559
pubmed: 29795437
Hum Pathol. 2013 Jan;44(1):103-9
pubmed: 22939958
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Pharmacol Ther. 2018 Oct;190:15-23
pubmed: 29730444
Int J Gynecol Pathol. 2003 Oct;22(4):324-33
pubmed: 14501811
Int J Gynecol Pathol. 2012 Jan;31(1):48-56
pubmed: 22123723
Mod Pathol. 2017 Jul;30(7):1032-1041
pubmed: 28281553
Hum Pathol. 2008 Jan;39(1):116-25
pubmed: 17949789
Br J Cancer. 2015 Jul 14;113(2):299-310
pubmed: 26172027
Mod Pathol. 2014 Feb;27(2):255-61
pubmed: 23887303
Adv Anat Pathol. 2017 Nov;24(6):311-335
pubmed: 28777143
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:xxiii
pubmed: 29644667
Mod Pathol. 2015 Jun;28(6):836-44
pubmed: 25720322
Nat Rev Cancer. 2011 Jun 09;11(7):481-92
pubmed: 21654818
Gynecol Oncol. 2018 Sep;150(3):426-431
pubmed: 30126589
Am J Clin Pathol. 2019 Apr 2;151(5):529-538
pubmed: 30715091
J Pathol. 2020 Mar;250(3):336-345
pubmed: 31829441
J Natl Cancer Inst. 2014 Sep 10;106(9):
pubmed: 25214561
Am J Surg Pathol. 2013 Nov;37(11):1728-36
pubmed: 24061515
J Pathol. 2011 Jul;224(3):328-33
pubmed: 21590771
Nat Med. 2018 May;24(5):556-562
pubmed: 29736026
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
J Immunother Cancer. 2020 Feb;8(1):
pubmed: 32111729
Am J Surg Pathol. 2013 Jun;37(6):874-81
pubmed: 23629444
Ann Oncol. 2018 May 1;29(5):1180-1188
pubmed: 29432521
BMC Cancer. 2010 May 05;10:180
pubmed: 20444249
Ann Oncol. 2016 Jan;27(1):16-41
pubmed: 26634381
Clin Cancer Res. 2016 Aug 15;22(16):4215-24
pubmed: 27006490
Mol Carcinog. 1999 Jul;25(3):207-18
pubmed: 10411147
Gynecol Oncol. 2019 Nov;155(2):374-383
pubmed: 31472940
Diagnostics (Basel). 2020 Apr 23;10(4):
pubmed: 32340363
Cancer Discov. 2015 Jul;5(7):752-67
pubmed: 26069190
Mod Pathol. 2013 Nov;26(11):1525-35
pubmed: 23702729
Int J Mol Sci. 2020 Sep 29;21(19):
pubmed: 33003368
J Pathol. 2020 Mar;250(3):323-335
pubmed: 31829442
Eur J Gynaecol Oncol. 2012;33(4):376-81
pubmed: 23091894
Hum Pathol. 2018 Feb;72:100-106
pubmed: 29133142
Gynecol Oncol. 2009 Feb;112(2):342-7
pubmed: 19062082
Am J Surg Pathol. 2011 May;35(5):625-32
pubmed: 21412130
Nature. 2013 May 2;497(7447):67-73
pubmed: 23636398
Gynecol Oncol. 2016 Aug;142(2):317-22
pubmed: 27288544